GlassScriptPhysician profile
Scott T Croft
NPI 1619934163
$1,179.55
in general payments reported to CMS, 2019-2025
19 companies · $222 in 2025
The $222 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86.85 · 2020: $89.03 · 2021: $123 · 2022: $222 · 2023: $199 · 2024: $237 · 2025: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $644 · Education: $14.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $643.63 |
| Education | $14.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $215.47 | 2019-2025 | Physio-Stim, Accelstim |
| Stryker Corporation | $209.23 | 2021-2025 | Pangea, Variax, Tornier Perform Reversed Glenoid |
| Davol INC. | $171.89 | 2021-2023 | Arista Ah Flexitip |
| Depuy Synthes Sales INC. | $137.51 | 2019-2025 | Monovisc |
| Smith+Nephew, INC. | $94.06 | 2021-2023 | Stravix, Grafix Pl |
| Bioventus LLC | $52.93 | 2021-2024 | Exogen Ultrasound Bone Healing System |
| Impactortho, INC. | $45.18 | 2024 | |
| Paratek Pharmaceuticals, INC. | $42.31 | 2022-2023 | Nuzyra |
| Wright Medical Technology, INC. | $28.91 | 2020 | |
| Sanofi-Aventis U.S. LLC | $27.47 | 2019-2020 | |
| Innovation Technologies INC | $20.68 | 2022 | |
| Heron Therapeutics, INC. | $20.56 | 2022 | |
| Celularity INC. | $20.00 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.87 | 2022 | |
| Baudax Bio INC. | $16.63 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $16.43 | 2019 | |
| Ethicon US, LLC | $15.91 | 2025 | Monovisc |
| Vericel Corporation | $14.86 | 2023 | Maci |
| Skeletal Dynamics INC | $11.65 | 2024 | Ijs, Geminus, Implate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Croft listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.